Abstract
Dyspnoea is one of the most frequent and refractory symptoms in cancer patients. Lack of an appropriate assessment tool for dyspnoea seems to disturb establishment of management strategy. The purpose of this study was to develop and validate a brief self-rating scale to assess the multidimensional nature of dyspnoea in cancer patients. We developed a 12-item scale, the Cancer Dyspnoea Scale (CDS), composed of three factors (sense of effort/sense of anxiety/sense of discomfort), by using factor analysis. One hundred and sixty-six patients with advanced or recurrent lung cancer participated in the validation phase. The CDS showed good feasibility (average time required to complete it was 140 s). Construct validity, confirmed by repeating factor analysis, was good. Convergent validity, confirmed by a relation to Visual Analogue Scale of dyspnoea and modified Borg’s scale, was also good (average: r = 0.57 and 0.52, respectively, and both P< 0.001). The CDS had good internal consistency (average Cronbach’s alpha = 0.86) and stability (average test-retest reliability r = 0.66, P< 0.005). The present study demonstrated that the CDS is a brief, valid and feasible scale for assessing the multidimensional nature of dyspnoea in cancer patients. © 2000 Cancer Research Campaign
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Ahmedzai S (1998) Palliation of respiratory symptoms. In: Oxford Textbook of Palliative Medicine, Doyle D, Hanks GWC, MacDonald N (eds), pp. 583–616, Oxford University Press: Oxford
American Thoracic Society (1978) Recommended respiratory disease questionnaires for use with adults and children in epidemiological research. Am Rev Respir Dis 118: 7–53
Atkin RCB (1969) Measurement of feelings using visual analogue scales. Proc R Soc Med 62: 989–993
Bonomi AE, Cella DF, Hahn EA, Bjordal K, Sperner-Unterweger B, Gngeri L, Bergman B, Willems-Groot J, Hanquet P and Zittoun R (1996) Multilingual translation of the Functional Assessment of Cancer Therapy (FACT) quality of life measurement system. Qual Life Res 5: 309–320
Borg G (1970) Perceived exertion as an indicator of somatic stress. Scand J Rehabil Med 2: 92–98
Bruera E and Ripamonti C (1998) Dyspnea in patients with Advanced cancer. Principles and Practice of Supportive Oncology, Berger A (ed). Lippincott-Raven: Philadelphia pp. 295–308
Burdon JGW, Killan KJ and Jones NJ (1983) Pattern of breathing during exercise in patients with interstitial lung disease. Thorax 38: 778–784
Burns BH and Howell JBL (1969) Disproportionaly severe breathlessness in chronic bronchitis. Q J Med 38: 277–294
Catell RB (1978). The scientific use of factor analysis in behavioral and life sciences, Plenum Press: New York
Dales RE, Spitzer WO, Schechter MT and Suissa S (1989) The influence of psychological status on respiratory symptom reporting. Am Rev Respir Dis 139: 1459–1463
Daut RL, Cleeland CS and Flanery RC (1983) Development of the Wisconsin Brief Pain Questionnaire to assess pain in cancer and other disease. Pain 17: 197–210
Elliott MW, Adams L, Cockcroft A, Macrae KD, Murphy K and Guz A (1991) The language of breathlessness: use of verbal descriptors by Patient swith cardiopulmonary disease. Am Rev Respir Dis 144: 826–832
Fletcher CM, Elmes PC, Fairbairn AS and Wood CH (1959) The significance of respiratory symptoms and the diagnosis of chronic obstructive pulmonary disease. Qual Life Res 2: 257–266
Gift A (1989) Validation of a vertical visual analogue scale as a measure of clinical dyspnoea. Rehab Nursing 14: 323–325
Gift A and Cahill C (1990) Psychophysiologic aspects of dyspnoea in chronic obstructive pulmonary disease: a pilot study. Heart Lung 19: 252–259
Higginson I and McCarthy M (1989) Measuring symptoms in terminal cancer; are pain and dyspnoea controlled?. J R Soc Med 82: 264–267
Kaiser HF (1960) The application of electronic computers to factor analysis. Educational and Psychological Measurements 20: 141–151
McCord M and Croin-Stubbs D (1992) Operationalizing dyspnoea: focus on measurement. Heart Lung 21: 167–179
McGavin CR, Artvinli M, Naoe H and McHardy GJR (1978) Dyspnoea, disability and distance walked: comparison of estimates of exercise performance in respiratory disease. Br Med J 2: 241–243
Mador MJ, Rodis A and Magalang UJ (1995) Reproducibility of Borg scale measurements of dyspnoea during exercise in patients with COPD. Chest 107: 1590–1597
Maler DA, Rosiello RA, Harver A, Lentine T, McGovern J and Daubenspeck J (1987) Comparison of clinical dyspnoea ratings and psychophysical measurements of respiratory sensation in obstructive airway disease. Am Rev Respir Dis 135: 1229–1233
Manning HL and Schwartztstein RM (1995) Pathophysiology of dyspnoea. N Engl J Med, 333 23: 1547–1553
Medical Research Council Committee on the Aetiology of Chronic Bronchitis (1965) Standardized questionnaires on respiratory symptoms. Br Med J 2: 1665
Moody L, McCormick K and Williams A (1990) Disease and symptom severity, functional status and quality of life in chronic bronchitis and emphysema (CBE). Behav Med 13: 297–306
Muza SR, Silverman MT, Gilmore GC, Hellerstein HK and Kelsen SG (1990) Comparison of scales used to quantitate the sense of effort to breath in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 141: 909–913
Nakazato K and Mizuguchi T (1982) Development and validation of Japanese version of State-Trait Anxiety Inventory: a study with female subjects (in Japanese). Jpn J Psychosomatic Medicine 22: 107–112
Nunnally JC and Bernstein IH (1994). Psychometric Theory, 482–484, McGraw-Hill: New York
O’Connor PJ, Raglin JS and Morgan WP (1996) Psychometric correlates of perception during arm ergometry in males and females. Int J Sports Med 17: 462–466
Reuben DB and Mor M (1986) Dyspnoea in terminal cancer patients. Chest 89: 234–236
Ripamonti C and Bruera E (1997) Dyspnoea: pathophysiology and assessment. J Pain Symptom Manag 13: 220–232
Simon PM, Shwartzstein RM, Weiss W, Lahive K, Fencl V, Teghtsoonian M and Weinberger SE (1989) Distinguishable sensations of breathlessness induced in normal volunteers. Am Rev Respir Dis 140: 1021–1027
Simon PM, Shwartzstein RM, Weiss W, Fencl V, Teghtsoonian M and Weinberger SE (1990) Distinguishable types of dyspnoea in patients with shortness of breath. Am Rev Respir Dis 142: 1009–1014
Spielberger CD, Gorsuch RL and Lushene RE (1970). STAI Manual, Consulting Psychologists Press: Palo Alto
Stoller JK, Ferranti R and Feinstein AR (1986) Further specification and evaluation of a new clinical index for dyspnoea. Am Rev Respir Dis 134: 1129–1134
Wolkove N, Dajczman E, Colacone A and Kreisman H (1989) The relationship between pulmonary function and dyspnoea in obstructive lung disease. Chest 96: 1247–1251
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Tanaka, K., Akechi, T., Okuyama, T. et al. Development and validation of the Cancer Dyspnoea Scale: a multidimensional, brief, self-rating scale. Br J Cancer 82, 800–805 (2000). https://doi.org/10.1054/bjoc.1999.1002
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1054/bjoc.1999.1002
Keywords
This article is cited by
-
Validity and reliability of the Turkish version of “the Dyspnea-ALS-Scale (DALS-15)”
Neurological Sciences (2022)
-
Tai Chi Chuan in postsurgical non-small cell lung cancer patients: study protocol for a randomized controlled trial
Trials (2018)
-
Prospective cohort study of cancer patients diagnosed with incidental venous thromboembolism on routine computed tomography scans
Supportive Care in Cancer (2017)
-
A randomised, double-blind controlled trial of intranasal midazolam for the palliation of dyspnoea in patients with life-limiting disease
Supportive Care in Cancer (2016)
-
Lebensqualitätsmessung in klinischen Studien beim Lungenkarzinom — Übersicht anhand der Datenbank ClinicalTrials.gov
PharmacoEconomics German Research Articles (2012)